Get notified when VXRT files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCritical incident detected
Existential event · Existential event
Time-sensitive event — see the red-flag panel below for the source-quoted detail.
Red Flags Detected
- Going Concern (new) — The company explicitly states substantial doubt about its ability to continue as a going concern.
- Delisting (new) — The company faces potential delisting from Nasdaq due to non-compliance with the minimum bid price requirement.
Vaxart launches at-the-market offering of up to $50M at $0.58/share, with immediate $0.26/share dilution
Filed March 21, 2025 · ~2 min read
Key Changes
-
high
Vaxart is selling up to $50 million of common stock in an at-the-market offering, with proceeds going to the company for general corporate purposes.
The Offering verify on EDGAR → -
high
The assumed offering price is $0.5754 per share, based on the last reported sale price on March 17, 2025; actual sales will occur at market prices.
The Offering verify on EDGAR → -
high
New investors will experience immediate dilution of $0.26 per share, as the as-adjusted net tangible book value per share is only $0.32.
Dilution verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FUL 10-Q) is open in full — no account needed.
Partner
Trade VXRT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify